New breakthrough bee vaccine technology could help combat colony declines

Beekeepers across the U.S. got a nasty surprise this year. Millions of pollinating bees were dead, with reports coming in across the country. Now, one company specializing in honeybee health says it might have a solution to the problem.

Georgia-based Dalan Animal Health says recent colony losses have created big challenges for keepers and farmers, which is why they have developed a vaccine. It exposes quee bees to inactive diseases, allowing them to give immunity to the rest of the hive. Developers have been testing the vaccine since 2022 in over 200 hives.

New numbers show commercial beekeepers lost around 62 percent of the nation’s pollinating supply over the winter. Keepers at Project APIS-M found several issues are causing the drop, including parasites and a lack of food. Honeybees help fertilize 75 percent of the world’s supplies.

LATEST STORIES BY THIS AUTHOR:

CLAAS Senior Vice President for the Americas Region Eric Raby joined us to preview the new docuseries “CLAAS: Made for More,” premiering tonight at 9 PM ET only on RFD-TV.
Dairy farmer and Discover Ag co-host Tara Vander Dussen joined us to discuss the Whole Milk for Healthy Kids Act, her experience at the signing, and what’s next for her family and farm.
The Farm Bureau is making an urgent call to Congress for more farm support. Colton Lacina with Farmers National Company joined us to discuss farmland values and how market dynamics for the year ahead reflect stabilization rather than collapse.
Analysts say a Supreme Court decision on tariffs could reshape protein markets, strain U.S.-China trade, and force farmers to rethink global demand strategies.
Wayne Cockrell with the Texas and Southwestern Cattle Raisers Association joined us to discuss preparedness, producer awareness, and the industry’s response to New World screwworm concerns.
President Donald Trump speaks at the World Economic Forum in Davos, addressing SNAP spending, tariff threats against Europe, market reactions, and the upcoming USMCA review.